Dengfeng Liu

Dengfeng Liu is currently the Head of Analytical Development and Quality Control at Arrivent Biopharma since November 2021. Prior experience includes serving as Sr. Director of Analytical Development at Ultragenyx Pharmaceutical Inc. from September 2019 to November 2021, and as Associate Director of Analytical Science at MedImmune from February 2017 to September 2019. Dengfeng Liu has also held positions at Gilead Sciences as Sr. Research Scientist I in Biologics Analytical Operations, Novartis as Development Investigator II in the Biotherapeutics Development Unit, and Amgen as Sr. Scientist in Formulation & Analytical Resources. Dengfeng Liu earned a Ph.D. in Chemistry from UC Santa Barbara and a BS in Chemistry from Peking University.